The unique molecular mechanism of Ano1, including Cl− channel activity and ability to physically interact with other proteins, contributes to its strong regulatory effects on osteoporosis and osteopetrosis and advances our understanding of bone metabolism related diseases. This evidence concerns the gene ANO1 and osteopetrosis.